Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Mar 22, 2026

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Published on: June 10, 2022

mRNA vaccine delivery using lipid nanoparticles.

Andreas M Reichmuth^1,2, Matthias A Oberli^1,2, Ana Jaklenec²

¹Department of Chemical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.

Therapeutic Delivery

|April 15, 2016

Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Electronic Polarization Governs Structure-Transport Coupling of Angstrom-Scale Confined Water.

ACS nano·2026

Same author

Am80-lipid nanoparticles serve as an enteric mucosal adjuvant following parenteral immunization with inactivated polio vaccine.

Science advances·2026

Same author

Microneedle array platforms for drug delivery and biomarker sensing: From skin mechanics guided design to scalable manufacture for clinical utility.

Journal of controlled release : official journal of the Controlled Release Society·2026

Same author

Engineering Tolerance: Nobel Insights from Immunology and MOFs and Their Implications for Nanoscience.

ACS nano·2026

Same author

Hybrid microneedle patch for administration of measles and rubella vaccine with an on-patient medical record.

Journal of controlled release : official journal of the Controlled Release Society·2026

Same author

The critical role of food fortification in combatting malnutrition and disease susceptibility in Africa.

Communications medicine·2025

Messenger RNA (mRNA) vaccines generate strong immune responses. Lipid nanoparticles offer a promising delivery system for mRNA vaccines, enhancing their clinical translation for cancer and prophylactic applications.

Area of Science:

Immunology
Biotechnology
Vaccinology

Background:

Messenger RNA (mRNA) vaccines induce robust immune responses, including antibody and cytotoxic T cell production.
mRNA vaccine technology holds significant promise for both cancer immunotherapy and prophylactic applications.
Effective delivery systems are crucial for the clinical success and widespread adoption of mRNA vaccines.

Purpose of the Study:

To highlight the potential of mRNA vaccines in immunotherapy and prophylaxis.
To emphasize the importance of efficient mRNA vaccine delivery systems.
To identify promising nonviral vectors for mRNA vaccine delivery.

Main Methods:

Review of current research on mRNA vaccine technology.
Evaluation of lipid nanoparticles as a nonviral vector system for mRNA delivery.

Keywords:

adjuvant cancer immunotherapy cationic lipid drug delivery lipid nanoparticle mRNA oligonucleotide therapeutic vaccine vaccine

More Related Videos

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Published on: February 25, 2021

Related Experiment Videos

Last Updated: Mar 22, 2026

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Published on: June 10, 2022

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Published on: February 25, 2021

Analysis of the characteristics and advantages of lipid nanoparticles.

Main Results:

Lipid nanoparticles (LNPs) are a highly promising nonviral vector for mRNA delivery.
LNPs offer advantages such as ease of scalable synthesis, mRNA protection, and facilitated endosomal escape.
LNPs can be functionalized for cell targeting and co-delivered with adjuvants.

Conclusions:

Lipid nanoparticles represent a key enabling technology for the successful clinical translation of mRNA vaccines.
The versatility of LNPs supports their application in diverse vaccine strategies, including cancer immunotherapy and prophylactic vaccines.
Further development and optimization of LNP-based delivery systems will be critical for advancing mRNA vaccine platforms.